VYVGART HYTRULO Trademark

Trademark Overview

On Monday, February 13, 2023, a trademark application was filed for VYVGART HYTRULO with the United States Patent and Trademark Office. The USPTO has given the VYVGART HYTRULO trademark a serial number of 97792721. The federal status of this trademark filing is FIRST EXTENSION - GRANTED as of Thursday, September 19, 2024. This trademark is owned by argenx B.V.. The VYVGART HYTRULO trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of autoimmune diseases and disorders
vyvgart hytrulo

General Information

Serial Number97792721
Word MarkVYVGART HYTRULO
Filing DateMonday, February 13, 2023
Status730 - FIRST EXTENSION - GRANTED
Status DateThursday, September 19, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 23, 2024

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of autoimmune diseases and disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, March 2, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party Nameargenx B.V.
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressZwijnaarde B-9052
BE
Party Nameargenx B.V.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressZwijnaarde B-9052
BE

Trademark Events

Event DateEvent Description
Thursday, February 16, 2023NEW APPLICATION ENTERED
Thursday, March 2, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, May 4, 2023ASSIGNED TO EXAMINER
Friday, June 2, 2023SUSPENSION LETTER WRITTEN
Friday, June 2, 2023LETTER OF SUSPENSION E-MAILED
Friday, June 2, 2023NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Thursday, June 29, 2023TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Monday, December 4, 2023ASSIGNED TO LIE
Tuesday, December 5, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, December 5, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, December 14, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, March 19, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, September 3, 2024TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Wednesday, January 3, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, January 23, 2024PUBLISHED FOR OPPOSITION
Tuesday, January 23, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 3, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, September 3, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, September 3, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, September 3, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, September 3, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, September 19, 2024SOU TEAS EXTENSION RECEIVED
Thursday, September 19, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, September 19, 2024SOU EXTENSION 1 FILED
Thursday, September 19, 2024SOU EXTENSION 1 GRANTED
Monday, October 7, 2024SOU TEAS EXTENSION RECEIVED
Monday, October 7, 2024TEAS STATEMENT OF USE RECEIVED

Related Keywords

hytrulo vyvgart diseases disorders autoimmune treatment preparations pharmaceutical